News

A research team has clarified the structure of a protein complex which is an important regulator of cellular degradation processes.

MIT researchers created a machine-learning model that can directly predict the complex that will form when two proteins bind together. Their technique is between 80 and 500 times faster than state-of-the-art software methods, and often predicts protein structures that are closer to actual structures that have been observed experimentally.

Scientists at The Wistar Institute have developed a more targeted COVID-19 vaccine that, in animal studies, shows stronger, broader, and more durable protection in a single, low dose.

Renowned scientists and engineers from the Massachusetts Institute of Technology (MIT) have developed and tested a capsule-based system for oral delivery of mRNA therapeutics.

A phase one clinical trial testing an mRNA vaccine designed to induce B-cell immune responses in HIV patients has begun.

Researchers have altered the SARS-CoV-2 spike protein to enable replication and infection in mice, demonstrating that the ACE2 receptor is key for virus entry into host cells.

Scientists from the University of Freiburg’s livMatS Cluster of Excellence have succeeded in developing a muscle solely on the basis of natural proteins.

Researchers have developed an approach that accelerates the detection of cancer biomarkers in samples taken at the time and place of patient care.

Structural proteomics can resolve the detailed structure of protein interactions and therefore may progress understanding of neurodegenerative disease treatments.

Researchers have discovered a way to modify the message containing the instruction for CFTR, forcing the protein-making machinery to skip over this “stop sign” mutation, which allows a functional version of the protein to be made.